About this trial

This study will examine the effects of Eye Movement Desensitization and Reprocessing (EMDR) group therapy on adults who experienced the April 2025 Silivri earthquake in Turkey. Participants will be randomly assigned to either an EMDR intervention group or a waitlist control group. Psychological symptoms will be measured using the PTSD Checklist for DSM-5 (PCL-5), the Depression, Anxiety, and Stress Scale (DASS-21), the Short Form Health Survey (SF-36), and the Pittsburgh Sleep Quality Index (PSQI). Quantitative EEG (QEEG) recordings will also be collected before and after the intervention to assess changes in brain activity related to emotional regulation and trauma processing. The goal of the study is to evaluate whether EMDR produces both clinical and neurophysiological improvements in trauma-exposed individuals.

Eligibility criteria

Qualifiers

Meeting DSM-5 criteria for posttraumatic stress symptoms following the April 2025 Silivri earthquake

Age between 18 and 50 years

Either medication-free for at least 1 month or on a stable dose of psychotropic medication

No medical contraindications for EEG recording (e.g., no epilepsy, no metal implants)

Disqualifiers

Current diagnosis of schizophrenia, bipolar disorder, or a neurological disorder

Receiving psychotherapy

Inability to attend sessions regularly due to logistical or cognitive limitations

Trial design

Treatments tested in this trial

  • Eye Movement Desensitization and Reprocessing (EMDR) Group Therapy

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Istanbul Galata University

Lead sponsor